OOIR: Observatory of International Research

Papers

(The H4-Index of Globalization and Health is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era	84
Comprehensive Medical Support in Complex Emergencies (CMSCE): pilot course review	76
North Korea’s COVID-19 policy dilemma: epidemic prevention conflicting with trade	68
Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19?	62
The alcohol industry’s involvement with road safety NGOs	61
Correction: Assessing the effects of mining projects on child health in sub-Saharan Africa: a multi-country analysis	58
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response	57
Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking	57
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics	56
Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists	49
Public health consequences after ten years of the Syrian crisis: a literature review	47
Analysing the impact of trade agreements on national food environments: the case of Vanuatu	46
Capturing sources of health system legitimacy in fragmented conflict zones under different governance models: a case study of northwest Syria	41
Labor migration is associated with lower rates of underweight and higher rates of obesity among left-behind wives in rural Bangladesh: a cross-sectional study	40
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials	40
Mental health solutions for domestic violence victims amid COVID-19: a review of the literature	39
Universal coverage of the first antenatal care visit but poor continuity of care across the maternal and newborn health continuum among Nepalese women: analysis of levels and correlates	38
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region	38
From isolation to revival: trade recovery amid global health crises	37
Characteristics and outcomes of the drug patent linkage system in China	37
Securing the rights and health of domestic workers: the importance of ratifying the ILO’s C189	37
Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020	37
Global infectious disease research collaborations in crises: building capacity and inclusivity through cooperation	34
Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada’s Healthy Eating Strategy	30
The politics of glyphosate regulation: lessons from Sri Lanka’s short-lived ban	30

Vaccine nationalism will persist: global public goods need effective engagement of global citizens	29
Food insecurity, COVID-19 and diets in Fiji – a cross-sectional survey of over 500 adults	29
Who influences nutrition policy space using international trade and investment agreements? A global stakeholder analysis	29
“We have to look deeper into why”: perspectives on problem identification and prioritization of women’s and girls’ health across United Nations agencies	29
Learning from COVID-19: government leaders’ perspectives to improve emergency risk communication	29